Nussbacher Julia K, Batra Ranjan, Lagier-Tourenne Clotilde, Yeo Gene W
Department of Cellular and Molecule Medicine, Institute for Genomic Medicine, UCSD Stem Cell Program, University of California, San Diego, La Jolla, CA, USA.
Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA, USA.
Trends Neurosci. 2015 Apr;38(4):226-36. doi: 10.1016/j.tins.2015.02.003. Epub 2015 Mar 9.
As critical players in gene regulation, RNA binding proteins (RBPs) are taking center stage in our understanding of cellular function and disease. In our era of bench-top sequencers and unprecedented computational power, biological questions can be addressed in a systematic, genome-wide manner. Development of high-throughput sequencing (Seq) methodologies provides unparalleled potential to discover new mechanisms of disease-associated perturbations of RNA homeostasis. Complementary to candidate single-gene studies, these innovative technologies may elicit the discovery of unexpected mechanisms, and enable us to determine the widespread influence of the multifunctional RBPs on their targets. Given that the disruption of RNA processing is increasingly implicated in neurological diseases, these approaches will continue to provide insights into the roles of RBPs in disease pathogenesis.
作为基因调控中的关键参与者,RNA结合蛋白(RBPs)在我们对细胞功能和疾病的理解中占据核心地位。在我们拥有台式测序仪和前所未有的计算能力的时代,可以以系统的、全基因组的方式解决生物学问题。高通量测序(Seq)方法的发展为发现与疾病相关的RNA稳态扰动的新机制提供了无与伦比的潜力。与候选单基因研究互补,这些创新技术可能引发对意外机制的发现,并使我们能够确定多功能RBPs对其靶标的广泛影响。鉴于RNA加工的破坏越来越多地与神经疾病有关,这些方法将继续为深入了解RBPs在疾病发病机制中的作用提供见解。